Digital therapy program for fibromyalgia receives FDA breakthrough device designation
newsdepo.com
Swing Therapeutics, a digital therapeutics startup, has received an FDA breakthrough device designation for their 12 week smartphone-assisted fibromyalgia management program. This is the company’s first breakthrough designation, and precedes a deluge of cli
Digital therapy program for fibromyalgia receives FDA breakthrough device designation
Swing Therapeutics, a digital therapeutics startup, has received an FDA breakthrough device designation for their 12 week smartphone-assisted fibromyalgia management program. This is the company’s first breakthrough designation, and precedes a deluge of clinical trials scheduled for this year. Swing Therapeutics was founded in 2019 and has raised a total of $9 million in seed […] Read more
